Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort
<b>Background:</b> This study assessed the long-term dynamics of neutralizing antibodies in a Ugandan cohort primarily exposed to the A.23.1 SARS-CoV-2 variant, examining how this shaped immune breadth and potency against diverse strains following infection and prototype-based vaccinatio...
Saved in:
| Main Authors: | Gerald Kevin Oluka, Jackson Sembera, Joseph Ssebwana Katende, Violet Ankunda, Laban Kato, Ashwini Kurshan, Carl Graham, Jeffrey Seow, Katie J. Doores, Michael H. Malim, Julie M. Fox, Pontiano Kaleebu, Jennifer Serwanga |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/2/143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles.
by: Jennifer Serwanga, et al.
Published: (2024-01-01) -
Assessment of the Level of Virus Neutralizing Antibodies to Enterovirus 71 in Children in Ekaterinburg (2010–2017)
by: O. M. Olenkova, et al.
Published: (2019-05-01) -
Clinical validation of an RSV neutralization assay and analysis of cross-sectional sera associated with 2021–2023 RSV outbreaks to investigate the immunity debt hypothesis
by: Eli A. Piliper, et al.
Published: (2024-12-01) -
An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
by: Tao Li, et al.
Published: (2023-12-01) -
CoreTIA: a modular, statistically robust transduction inhibition assay for AAV neutralization
by: Beatrix Kovács, et al.
Published: (2025-08-01)